Results
5
Stocks with a market cap under US$50M.
5 companies
Advicenne
Market Cap: €25.7m
A specialty pharmaceutical company, develops, commercializes, and markets treatments for rare renal diseases in France and internationally.
ALDVI
€1.82
7D
40.8%
1Y
95.3%
Theranexus Société Anonyme
Market Cap: €19.6m
A biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system disorders.
ALTHX
€2.30
7D
2.7%
1Y
289.8%
Pherecydes Pharma Société anonyme
Market Cap: €14.4m
Pherecydes Pharma Société anonyme develops antibacterial treatments based on the use of bacteriophage viruses or phages.
ALPHE
€2.00
7D
2.6%
1Y
-53.6%
Oncodesign Precision Medicine Société anonyme
Market Cap: €9.8m
A biopharmaceutical company, engages in the precision medicine business.
ALOPM
€0.54
7D
-28.3%
1Y
-47.5%
Aton
Market Cap: €6.4m
Operates as a bioscience company in France.
ALTAO
€0.0078
7D
8.3%
1Y
-37.1%